Matimba Molly Chilala

Matimba Molly Chilala

Auto-generated profile, based on publicly available information

Matimba Molly Chilala

Department of Public Health, Copperbelt University, Ndola, Zambia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
OSOlivier Sibomana
Olivier Sibomana
CHCLYDE HAKAYUWA
CLYDE HAKAYUWA
AOAbraham Obianke
Abraham Obianke
HGHubert Gahire
Hubert Gahire
JMJildas Munyantore
Jildas Munyantore
MCMatimba Molly Chilala
Matimba Molly Chilala
Atrial fibrillation (AF), the most common form of cardiac arrhythmia, is associated with significant morbidity, mortality, and financial burden. Traditional diagnostic methods, such as 12-lead electrocardiograms (ECG), have limitations in detecting intermittent AF episodes. Consequently, smart wearables have been introduced to enhance continuous AF monitoring. This systematic review and meta-analysis aimed to evaluate and compare the diagnostic accuracy of ECG smart chest patches and photoplethysmography (PPG)– based smartwatches in AF detection. From august 16–20, 2024, a comprehensive search was conducted across PubMed/MEDLINE, DOAJ, AJOL, and the Cochrane Library. Original studies assessing the performance of ECG smart chest patches and PPG smartwatches in detecting AF were included. Studies were screened based on predefined inclusion and exclusion criteria, and the most relevant were finally included. For ECG smart chest patches and PPG smartwatches groups, random-effects model was used to pool these performance metrics. Statistical analyses were performed using Jamovi 2.3.28, with a significance threshold of p < 0.05. A total of 15 studies were included in the current systematic review and meta-analysis. ECG smart chest patches demonstrated a pooled sensitivity of 96.1% [(95% CI: 91.3–100.8), (I² = 94.59%)], and a pooled specificity of 97.5% [(95% CI: 94.7–100.2), (I² = 79.1%)]. PPG smartwatches showed a pooled sensitivity of 97.4% [(95% CI: 96.5–98.3), (I² = 3.16%)], and a pooled specificity of 96.6% [(95% CI: 94.9–98.3), (I² = 75.94%)]. Comparatively, both ECG smart chest patches and PPG smartwatches exhibited excellent performance in atrial fibrillation detection, with PPG smartwatches showing slightly higher sensitivity and ECG chest patches exhibiting marginally greater specificity. Both ECG smart chest patches and PPG smartwatches are highly effective for detecting atrial fibrillation. However, further advancements are needed to match their accuracy with that of standard diagnostic methods and achieve comprehensive digital cardiac monitoring.